Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

We investigated the association between OAT engagement and providing injection drug use (IDU) initiation assistance across poly-drug use practices in Vancouver, Canada.

Original research | 2022
About PWUD, Outcomes, Illegal drugs, Injecting tablets

This paper proposes a stigma-vulnerability nexus as a critical incursion into understandings of and responses to drug-related social problems.

Original research | 2022
Stigma, Policy/Regulatory, Equity

BZDs are often a difficult drug class to cease once neuroadaptation has occurred; recommendations usually involve gradual dose reductions of variable rates.

Original research | 2022
Withdrawal, Clinical guidance
Manuel | 2020
la réduction des méfaits, les services enveloppants, À propos des prescripteurs, les services sociaux, les drogues illégales, les stimulants, s'injecter les comprimés
Video | 2022
Drug checking, Illegal drugs, Harm reduction
Guidelines | 2022
Clinical guidance, About prescribers, Injecting tablets

Underutilized regulations allow non-Opioid Treatment Program (OTP) providers to administer methadone for opioid withdrawal for up to 72 hours while arranging ongoing care.

Original research | 2022
Hospitals, Transitions in care/treatment, Substitution

As supervised consumption services (SCS) are scaled-up across Canada, information on those who require help injecting is necessary to inform equitable service uptake.

Original research | 2022
Equity, About PWUD, Illegal drugs, Sex/Gender , SCS/OPS

The objective was to employ latent class analysis (LCA) to empirically categorize and extract potential typologies of poly-substance users within a multi-site cohort of illicit opioid and other dru

Original research | 2009
About PWUD, Illegal drugs
Training | 2022
Harm reduction, About prescribers, Illegal drugs

Morphine preparations are known to have small amounts of codeine as an impurity estimated to be about 0.04%

Original research | 2009
Drug checking, Substitution
Case study | 2022
Safer supply, About prescribers, Policy/Regulatory, Wrap-around services, Barriers and enablers, Evidence base, Social services, Harm reduction
Commentary | 2022
Safer supply, About PWUD, Social benefits

Integrating the social-ecological framework, we focus on individual characteristics, personal and family members' experience with OUD, and spatial access to OUD at the community level.

Original research | 2022
Stigma

The purpose of this paper is to provide findings related to two research questions: first,do low-threshold employment programmes have the potential to contribute to positive recovery capital, and i

Original research | 2016
Peer/PWLLE program involvement

This paper asks, what values do people who use drugs hold surrounding drug use and drug policy, and what factors predict these values?

Original research | 2022
About PWUD, Policy/Regulatory

We estimated the impact of OAT on hospitalisations for non-viral infections and examine trends in incidence over time.

Original research | 2022
Substitution, Injecting tablets, About PWUD, Outcomes, Illegal drugs, Hospitals
Slide deck | 2022
Hospitals, Harm reduction, Policy/Regulatory, Stigma

Refine Your Search

Keywords
Format
Region